On December 12, 2019, the Alberta government introduced the Alberta Biosimilar Initiative. This communication is to inform you the switching requirement of the Biosimilar Initiative is postponed from
July 1, 2020 to January 15, 2021 due to the COVID-19 pandemic.
Adult patients currently on an originator biologic drug for which there is a biosimilar version for their medical condition must switch to the biosimilar before January 15, 2021 to maintain coverage for that drug through an Alberta government sponsored drug plan. The Alberta Biosimilar Initiative does not apply to other coverage such as employer group coverage.
At this time:
• If you have begun taking a biosimilar medication, please continue taking the biosimilar. Do not stop taking the biosimilar drug or switch back to your biologic drug.
• If you have a new prescription for a biosimilar but have not yet started the new medication, please continue working with the patient support program or your pharmacy to start your biosimilar.
• If you have a new prescription for a biosimilar administered intravenously (IV), please contact the patient support program to arrange your infusion. If you have an appointment scheduled with an infusion clinic, please attend your appointment as scheduled or as otherwise instructed by the clinic.
• If you have not yet switched to a biosimilar medication, but have scheduled an appointment with your physician, please continue taking your biologic medication until meeting with your physician. Please attend your appointment as scheduled or as otherwise instructed by your physician.
Updated patient information can be found at:
https://www.ab.bluecross.ca/pdfs/Patient-Info-Biosimilars.pdf
The Canadian Organization for Rare Disorders Hereby Gives Notice of its Annual General Meeting: August 26, 2024 at 2:00 PM (EDT) via videoconference
CORD Annual General MeetingAugust 26, 2024 at 2:00 PM (EDT) via videoconference Dear CORD Members: The Canadian Organization for Rare Disorders gives notice of it's Annual General Meeting on August 26, 2024 at 2pm - 3pm (Eastern Time). All individual, affiliate and corporate members in good standing are invited participate. An eligible voter must be a representative of a voting member of CORD. Eligible voters may either vote at the upcoming Annual General Meeting videoconference or by proxy. Votes by proxy must be in must be returned to us by August 25, 2024. Ballots received after this date and time, duplicate votes and spoiled ballots will not be counted. To participate in the AGM teleconference, please register by August 25, 2024 Registration: https://bit.ly/4aM8IJL Once we have received your response, we will email you the teleconference details and any other necessary documents that will be required for the meeting. Thank you for your participation and if you have any questions, please let me know. Sincerely, Christine White CORD Secretary PROXY-2024Download
The Canadian Organization for Rare Disorders Hereby Gives Notice of its Annual General Meeting: August 26, 2024 at 2:00 PM (EDT) via videoconference
CORD Annual General MeetingAugust 26, 2024 at 2:00 PM (EDT) via videoconference Dear CORD Members: The Canadian Organization for Rare Disorders gives notice of it's Annual General Meeting on August 26, 2024 at 2pm - 3pm (Eastern Time). All individual, affiliate and corporate members in good standing are invited participate. An eligible voter must be a representative of a voting member of CORD. Eligible voters may either vote at the upcoming Annual General Meeting videoconference or by proxy. Votes by proxy must be in must be returned to us by August 25, 2024. Ballots received after this date and time, duplicate votes and spoiled ballots will not be counted. To participate in the AGM teleconference, please register by August 25, 2024 Registration: https://bit.ly/4aM8IJL Once we have received your response, we will email you the teleconference details and any other necessary documents that will be required for the meeting. Thank you for your participation and if you have any questions, please let me know. Sincerely, Christine White CORD Secretary PROXY-2024Download
Join us and become part of an active Canadian rare disorder community. The only national organization representing all rare disorder patient groups in Canada.
LEARN MORE